Valmark Advisers, Inc. Castle Biosciences Inc Transaction History

Valmark Advisers, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$22.51 - $34.32 $15,689 - $23,921	-697 Reduced 5.38%	12,269 $320,000
Q2 2022 Aug 01, 2022	BUY	$16.0 - $45.99 $56,544 - $162,528	3,534 Added 37.47%	12,966 $285,000
Q1 2022 May 10, 2022	BUY	$33.17 - $46.98 $4,909 - $6,953	148 Added 1.59%	9,432 $423,000
Q4 2021 Feb 02, 2022	BUY	$39.06 - $67.58 $10,155 - $17,570	260 Added 2.88%	9,284 $398,000
Q3 2021 Nov 09, 2021	BUY	$60.13 - $77.6 $13,769 - $17,770	229 Added 2.6%	9,024 $600,000
Q2 2021 Aug 06, 2021	BUY	$50.07 - $76.78 $17,574 - $26,949	351 Added 4.16%	8,795 $645,000
Q1 2021 May 04, 2021	SELL	$58.92 - $97.33 $190,665 - $314,959	-3,236 Reduced 27.71%	8,444 $578,000
Q4 2020 Feb 03, 2021	BUY	$43.6 - $73.05 $509,248 - $853,224	11,680 New	11,680 $784,000

201

24.5M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $752M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Valmark Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Valmark Advisers, Inc. with notifications on news.